Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-20

Clinical Trial Update: Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study [Phase 2]

View source ↗

Summary

Phase 2 prospective open-label pilot study evaluating adjunctive omega-3 fatty acids for medically intractable epilepsy; no efficacy results are provided in the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Epilepsy | Phase 2 | Status: UNKNOWN